Pain medicine

HSK21542 for Postoperative Analgesia in Gynecological Surgery: A Pooled Post-Hoc Analysis of Two Phase III Randomized Controlled Trials

Anesth AnalgPublished Pooled post-hoc analysis of two phase III randomised controlled trials

Authors' conclusion

HSK21542 could provide adequate postoperative analgesia with few adverse events in patients undergoing gynecological surgery.

Study context

Population
Patients undergoing elective gynecological surgeryanalysed
Participants
370 patients
Comparison
HSK21542 vs placebo vs tramadol
  • HSK21542n = 150
  • Placebon = 139reference
  • Tramadoln = 81
Primary endpoint
Summed pain-intensity difference over 12 and 24 h (SPID 12h and SPID 24h)
Follow-up
12 and 24 hours
Methodological detailsmulticentre, triple-blinded, inverse probability of treatment weighting (IPTW)-adjusted
  • Multicentre
  • Triple-blinded
  • IPTW-adjusted

Primary result

As reported in the abstract

SPID 12h and SPID 24h

Least-squares mean difference

−8.1

P < 0.001

Study 301: HSK21542 · SPID 12h

Least-squares mean difference

−16.3

P < 0.001

Study 303: HSK21542 · SPID 24h

Secondary outcomes

OutcomeHSK21542PlaceboP value
Relief from severe pain · 0 to 12 hoursHSK21542 vs Placebo92.7%82.7%P < 0.001
Rescue doses · 0 to 12 hoursHSK21542 vs Placebo0.00 (IQR 0.00–1.00)1.00 (IQR 0.00–2.00)P < 0.001
Rescue doses · 0 to 24 hoursHSK21542 vs Placebo0.00 (IQR 0.00–1.00)1.00 (IQR 0.00–2.00)P < 0.001

Rescue doses, HSK21542 vs tramadol · 0 to 12 and 0 to 24 hours

No significant differences with tramadol

Safety

OutcomeHSK21542Tramadol
Nausea24.7%66.7%
Vomiting21.3%60.5%
Dizziness— not stated in the abstract1 events

— not stated in the abstract

  • Nausea: significantly lower with HSK21542
  • Vomiting: significantly lower with HSK21542

Original publication

HSK21542 for Postoperative Analgesia in Gynecological Surgery: A Pooled Post-Hoc Analysis of Two Phase III Randomized Controlled Trials. Anesth Analg. Published 23 March 2026. doi:10.1213/ane.0000000000008004

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.